Literature DB >> 24458272

Not like a wrecking ball: EBV fine-tunes MYC lymphomagenesis.

Dirk P Dittmer1.   

Abstract

In this issue of Blood, Fish et al uncover how Epstein-Barr virus (EBV) enhances MYC-driven B-cell lymphoma by crossing EBV Em-EBV latent membrane protein 2A (LMP2A) transgenic mice with immunoglobulin-l (Igl)-MYC transgenic mice.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24458272      PMCID： PMC3901062          DOI： 10.1182/blood-2013-11-537076

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  10 in total

1.  Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.

Authors:  Kamonwan Fish; Jia Chen; Richard Longnecker
Journal:  Blood       Date:  2013-10-30       Impact factor: 22.113

2.  Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model.

Authors:  Baochun Zhang; Sven Kracker; Tomoharu Yasuda; Stefano Casola; Matthew Vanneman; Cornelia Hömig-Hölzel; Zhe Wang; Emmanuel Derudder; Shuang Li; Tirtha Chakraborty; Shane E Cotter; Shohei Koyama; Treeve Currie; Gordon J Freeman; Jeffery L Kutok; Scott J Rodig; Glenn Dranoff; Klaus Rajewsky
Journal:  Cell       Date:  2012-02-17       Impact factor: 41.582

3.  Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.

Authors:  Michael T Hemann; Anka Bric; Julie Teruya-Feldstein; Andreas Herbst; Jonas A Nilsson; Carlos Cordon-Cardo; John L Cleveland; William P Tansey; Scott W Lowe
Journal:  Nature       Date:  2005-08-11       Impact factor: 49.962

4.  Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

5.  Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

Authors:  Daniel Portal; Hufeng Zhou; Bo Zhao; Peter V Kharchenko; Elizabeth Lowry; Limsoon Wong; John Quackenbush; Dustin Holloway; Sizun Jiang; Yong Lu; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

6.  Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.

Authors:  W Kulwichit; R H Edwards; E M Davenport; J F Baskar; V Godfrey; N Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

7.  Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.

Authors:  Alexandra C Vrazo; Maria Chauchard; Nancy Raab-Traub; Richard Longnecker
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

8.  A surface groove essential for viral Bcl-2 function during chronic infection in vivo.

Authors:  Joy Loh; Qiulong Huang; Andrew M Petros; David Nettesheim; Linda F van Dyk; Lucia Labrada; Samuel H Speck; Beth Levine; Edward T Olejniczak; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

9.  Burkitt lymphoma in the mouse.

Authors:  A L Kovalchuk; C F Qi; T A Torrey; L Taddesse-Heath; L Feigenbaum; S S Park; A Gerbitz; G Klobeck; K Hoertnagel; A Polack; G W Bornkamm; S Janz; H C Morse
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

10.  The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas.

Authors:  Yosef Refaeli; Ryan M Young; Brian C Turner; Jennifer Duda; Kenneth A Field; J Michael Bishop
Journal:  PLoS Biol       Date:  2008-06-24       Impact factor: 8.029
  10 in total
  2 in total

1.  Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.

Authors:  Francesco Abate; Maria Raffaella Ambrosio; Lucia Mundo; Maria Antonella Laginestra; Fabio Fuligni; Maura Rossi; Sakellarios Zairis; Sara Gazaneo; Giulia De Falco; Stefano Lazzi; Cristiana Bellan; Bruno Jim Rocca; Teresa Amato; Elena Marasco; Maryam Etebari; Martin Ogwang; Valeria Calbi; Isaac Ndede; Kirtika Patel; David Chumba; Pier Paolo Piccaluga; Stefano Pileri; Lorenzo Leoncini; Raul Rabadan
Journal:  PLoS Pathog       Date:  2015-10-15       Impact factor: 6.823

2.  KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice.

Authors:  Sang-Hoon Sin; Yongbaek Kim; Anthony Eason; Dirk P Dittmer
Journal:  PLoS Pathog       Date:  2015-09-01       Impact factor: 6.823
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.